Bacterial co-infection is a known major source of sickness and death in the context of other respiratory viral infections such as influenza, parainfluenza or RSV. However, it has been unclear regarding the frequency of bacteremic co-infection in COVID-19 and the impact it has on clinical outco...
[7] Chen H, Xie J, Su N, et al. Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype[J]. Chest, 2021, 159(5):1793-1802. [8] Langford B J, So M, Raybar...
spread through this route is not a main feature of the outbreak. WHO is assessing ongoing research on the ways COVID-19 is spread and will continue to share new findings. Because this is a risk, however
infection in patients with COVID-19 is COVID-19-associated pulmonary aspergillosis (CAPA) [17, 18]. A review study showed that the incidence of CAPA was 15.1% among intensive care unit (ICU)-admitted patients with COVID-19 and that it was associated with increased mortality. Corticosteroids ...
Most patients with COVID-19 disease caused by the SARS-CoV-2 virus recover from this infection, but a significant fraction progress to a fatal outcome. As with some other RNA viruses, co-infection or activation of latent bacterial infections along with pre-existing health conditions in COVID-...
[7] Chen H, Xie J, Su N, et al. Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype[J]. Chest, 2021, 159(5):1793-1802. [8] Langford B J, So M, Raybardhan S, et al. Bacterial co-infection and secondar...
What is the ‘new normal’ in surgical procedures in the era of COVID-19? Cansu Cimen, Şiran Keske, Önder ErgönülJanuary 2021 Pages 16-18 View PDF select article Understanding the role of bacterial and fungal infection in COVID-19 DiscussionOpen archive Understanding the role of bacte...
to prevent deaths and reduce infections. However, many deaths associated with the flu and COVID-19 don't occur at the hand of the virus alone. Instead, it's asecondary bacterial infectionthat is often at the root of the devastating consequences attributed to an initial viral infection. ...
COVID-19 is a multi-system infection with emerging evidence-based antiviral and anti-inflammatory therapies to improve disease prognosis. However, a subset of patients with COVID-19 signs and symptoms have repeatedly negative RT-PCR tests, leading to treatment hesitancy. We used comparative serology...
55.Langford,B.J.;So,M.;Raybardhan,S.;Leung,V.;Westwood,D.;MacFadden,D.R.;Soucy,J.-P.R.;Daneman,N.Bacterialco-infectionandsecondaryinfectioninpatientswithCOVID-19:Alivingrapidreviewandmeta-analysis.Clin.Microbiol.Infect.2020,26,1622-1...